Integrated Physiology-Liver

Integrated Physiology-Liver

Open Access
Regulation of Hepatic Metabolism and Cell Growth by the ATF/CREB Family of Transcription Factors
Aoyuan Cui, Dong Ding, Yu Li

Diabetes Mar 2021, 70 (3) 653-664; DOI: 10.2337/dbi20-0006
You have access
Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease
Kasper W. ter Horst, Daniel F. Vatner, Dongyan Zhang, Gary W. Cline, Mariette T. Ackermans, Aart J. Nederveen, Joanne Verheij, Ahmet Demirkiran, Bart A. van Wagensveld, Geesje M. Dallinga-Thie, Max Nieuwdorp, Johannes A. Romijn, Gerald I. Shulman, Mireille J. Serlie

Diabetes Care Feb 2021, 44 (2) 489-498; DOI: 10.2337/dc20-1644
You have access
The Measurement of Insulin Clearance
Francesca Piccinini, Richard N. Bergman

Diabetes Care Sep 2020, 43 (9) 2296-2302; DOI: 10.2337/dc20-0750
Open Access
Comment on Liu et al. Aberrant Expression of FBXO2 Disrupts Glucose Homeostasis Through Ubiquitin-Mediated Degradation of Insulin Receptor in Obese Mice. Diabetes 2017;66:689–698
Siauyen Wong, Rick F. Nelson, Peiran Lu, Henry Paulson, Dingbo Lin

Diabetes Feb 2020, 69 (2) e1; DOI: 10.2337/db19-0975
Open Access
A High-Fat Diet Attenuates AMPK α1 in Adipocytes to Induce Exosome Shedding and Nonalcoholic Fatty Liver Development In Vivo
Chenghui Yan, Xiaoxiang Tian, Jiayin Li, Dan Liu, Ding Ye, Zhonglin Xie, Yaling Han, Ming-Hui Zou

Diabetes Feb 2021, 70 (2) 577-588; DOI: 10.2337/db20-0146
You have access
Postprandial Aminogenic Insulin and Glucagon Secretion Can Stimulate Glucose Flux in Humans
Teddy Ang, Clinton R. Bruce, Greg M. Kowalski

Diabetes May 2019, 68 (5) 939-946; DOI: 10.2337/db18-1138
You have access
Fasting-Induced Transcription Factors Repress Vitamin D Bioactivation, a Mechanism for Vitamin D Deficiency in Diabetes
Sanna-Mari Aatsinki, Mahmoud-Sobhy Elkhwanky, Outi Kummu, Mikko Karpale, Marcin Buler, Pirkko Viitala, Valtteri Rinne, Maija Mutikainen, Pasi Tavi, Andras Franko, Rudolf J. Wiesner, Kari T. Chambers, Brian N. Finck, Jukka Hakkola

Diabetes May 2019, 68 (5) 918-931; DOI: 10.2337/db18-1050
Open Access
A New FGF21 Analog for the Treatment of Fatty Liver Disease
Maximilian Kleinert, Timo D. Müller

Diabetes Aug 2020, 69 (8) 1605-1607; DOI: 10.2337/dbi20-0025
You have access
The Effects of B1344, a Novel Fibroblast Growth Factor 21 Analog, on Nonalcoholic Steatohepatitis in Nonhuman Primates
Aoyuan Cui, Jian Li, Shaohui Ji, Fengguang Ma, Genbei Wang, Yaqian Xue, Zhengshuai Liu, Jing Gao, Jun Han, Ping Tai, Tony Wang, Jianxun Chen, Xiaohui Ma, Yu Li

Diabetes Aug 2020, 69 (8) 1611-1623; DOI: 10.2337/db20-0209
You have access
Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes
Fernando Bril, Michael J. McPhaul, Michael P. Caulfield, Virginia C. Clark, Consuelo Soldevilla-Pico, Roberto J. Firpi-Morell, Jinping Lai, Dov Shiffman, Charles M. Rowland, Kenneth Cusi

Diabetes Care Feb 2020, 43 (2) 290-297; DOI: 10.2337/dc19-1071

Main menu

User menu

Search

Integrated Physiology-Liver

Pages

Navigation

Information

ADA Journals

Other ADA Resources